Enzolytics Inc (ENZC)

[Valuator2]

The debts remain in old ENZC, the predecessor, which was renamed to ENZC SUB, Inc and again later to Robusto, Inc. JMHO.:

it does not appear that Robustomed (A/K/A ENZC SUB) is responsible for the debt prior to the merger of Enzolytics and BioClonetics.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174649042

On November 16, 2020, the Company (having been renamed, immediately prior to this Holding Company
Reorganization, from “Enzolytics, Inc.” to “ENZC SUB, Inc.”) completed a corporate reorganization (the
“Holding Company Reorganization”) pursuant to which ENZC SUB, Inc., (the “Predecessor”) became a
direct, wholly owned subsidiary of a newly formed Delaware corporation, Enzolytics, Inc. (the “Holding
Company”), which became the successor issuer. In other words, the Holding Company is now the public
entity